For over 10 years, Matrix Cell Research Institute Inc. has been dedicated to finding alternatives to conventional cancer therapy. Our aim is to provide widely accessible solutions and technologies that are independent of facility restrictions, straightforward in their application and limit radiation exposure. With our efforts, we hope to greatly increase the number of successful cancer treatments and improve patients’ overall quality of life.
Our core business includes:
Research and development of medical devices and equipment for diagnosis of cancer metastasis
Development of anti-Tenascin antibody therapy
Research and development of medical supplies, medical-use cells, pharmaceuticals and diagnostic agents, as well as new technologies for diagnosis and treatment in regernerative medicine
Consulting and educational training for businesses on research and development in medicine and biology.
Our quality management system is EN ISO 13485:2016-certified (Certificate No.: 4201660)